IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus
about
Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosisThe potential of molecular markers to improve interventions through the natural history of oesophageal squamous cell carcinomaSTAT3: A Novel Molecular Mediator of Resistance to ChemoradiotherapyThe tumor microenvironment in esophageal cancerVariation and significance of secretory immunoglobulin A, interleukin 6 and dendritic cells in oral cancer.Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapyIL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.Impact of interleukin-6 -174 G>C gene promoter polymorphism on neuroblastoma.Association of angiogenic factors with prognosis in esophageal cancer.Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma.Prognostic Role of Phospho-STAT3 in Patients with Cancers of the Digestive System: A Systematic Review and Meta-Analysis.Expression of activated signal transducer and activator of transcription-3 as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma.Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma.Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival.Significance of Interleukin-6 in Papillary Thyroid Carcinoma.IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer.The role of PD-L1 in the radiation response and prognosis for esophageal squamous cell carcinoma related to IL-6 and T-cell immunosuppression.The role of IL-6 in the radiation response of prostate cancerCancer prevention and therapy through the modulation of the tumor microenvironment.Significance of DNMT3b in oral cancer.Reciprocal androgen receptor/interleukin-6 crosstalk drives oesophageal carcinoma progression and contributes to patient prognosis.Role of interleukin-6 in cancer progression and therapeutic resistance.Role of Postoperative C-Reactive Protein Levels in Predicting Prognosis After Surgical Treatment of Esophageal Cancer.Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer.The diagnostic and prognostic value of interleukin-6 in patients with soft tissue sarcomas.Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment.Targeting the IL-6/JAK/STAT3 signalling axis in cancer.Biochemical Properties of a Decoy Oligodeoxynucleotide Inhibitor of STAT3 Transcription Factor.Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancerCombined detection of IL-6 and IL-8 is beneficial to the diagnosis of early stage esophageal squamous cell cancer: a preliminary study based on the screening of serum markers using protein chips
P2860
Q26741263-F5EDD953-8E66-4562-A45B-2A4D43FA2ECEQ26829483-3185C09B-496E-4411-BD3D-FB32DF70D873Q27003190-AE9EE8A1-EAD5-44DA-B256-A1068F537695Q28077074-4FAA8E12-D1E0-4176-9294-3E44BF76219CQ33598073-476169F9-4F61-40BE-8B0E-7665E187B4B4Q33866426-835ECDED-5036-4FD6-B767-851787BB3C26Q34483744-17EE375D-56AB-478E-A1D5-264E26C29CB4Q35034812-219E32A1-7998-45F5-8E66-A266666890C7Q35185524-1DB91964-7062-45B3-BD9F-A0553D3E791CQ35342995-27D908B8-C8C9-45E7-9236-61A0A310E2A4Q35646263-50298A35-F897-49F6-8AEF-E4027BC7C665Q36266954-F1DF6D99-65F0-4524-A2B3-D257C9EE2D11Q36356086-AE9708C9-9DB1-4E2A-833C-0A88E15BFE9BQ36629387-6C22102B-C332-4504-9A4B-83AE54801025Q36731164-ADC95A80-4A30-4D67-9B4A-BB062CD950AEQ36916291-BEF6D7CD-A12E-433A-A5DB-89B45008CDF5Q36946662-CED5D37E-D709-4C60-AF56-BD913A08A633Q37028843-53496765-E7AF-4109-B0AE-AE3C394BD02EQ37058267-58731A09-7A74-4A43-A86B-0EE02DB5F905Q37635624-F45E757D-44A3-466E-BEC9-C0E211A28FB0Q38734599-6D642A3E-0EF1-4F27-B037-8CA30D0AF315Q38853625-5BC3D01F-99FC-4B39-AF06-35A11E580961Q40359356-359553EB-133F-4BBD-AD5A-D94BA997DEA1Q41471150-EBD8BCC9-C2EE-4BC7-AB90-7B44E59360F2Q41550528-9D9F36B8-2DD6-471A-BF17-47A3A9A7889FQ47829828-F569D98B-5D56-4403-B3FE-B16CD4757F7BQ50191433-DAC4557C-F6E5-4779-B4BC-00DD52026111Q55642764-310A9A91-8969-4A99-B9C0-13078F502AD0Q57115352-1F23B090-EF13-42FB-BE3C-B0022546F8C8Q58746752-52AEDD93-D1F2-4025-9033-F13917195C32
P2860
IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
IL-6 expression predicts treat ...... ell carcinoma of the esophagus
@en
type
label
IL-6 expression predicts treat ...... ell carcinoma of the esophagus
@en
prefLabel
IL-6 expression predicts treat ...... ell carcinoma of the esophagus
@en
P2093
P2860
P356
P1433
P1476
IL-6 expression predicts treat ...... ell carcinoma of the esophagus
@en
P2093
Kuan-Der Lee
Miao-Fen Chen
Ming Shian Lu
Paul Yang Lin
Ping-Tsung Chen
Wen-Cheng Chen
P2860
P2888
P356
10.1186/1476-4598-12-26
P577
2013-04-05T00:00:00Z
P5875
P6179
1011156460